---
figid: PMC6168472__41388_2017_26_Fig7_HTML
figlink: /pmc/articles/PMC6168472/figure/Fig7/
number: F7
caption: The proposed mechanistic model of KMT2D in prostate cancer. The KMT2D sustains
  cell H3K4me1 level in prostate cancer and facilitates the expression of a set genes,
  including LIFR and KLF4. LIFR upon activation of PI3K pathway, and activated AKT
  phosphorylates downstream target such as CREB and BRCA1, promoting tumor growth.
  KLF4 facilitates transcription of EMT pathways, leading to tumor metastasis
pmcid: PMC6168472
papertitle: Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis
  via epigenetically activating LIFR and KLF4.
reftext: Shidong Lv, et al. Oncogene. 2018;37(10):1354-1368.
pmc_ranked_result_index: '83663'
pathway_score: 0.9662507
filename: 41388_2017_26_Fig7_HTML.jpg
figtitle: Proposed mechanistic model of KMT2D in prostate cancer
year: '2018'
organisms: Homo sapiens
ndex: ec7e8685-ded0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6168472__41388_2017_26_Fig7_HTML.html
  '@type': Dataset
  description: The proposed mechanistic model of KMT2D in prostate cancer. The KMT2D
    sustains cell H3K4me1 level in prostate cancer and facilitates the expression
    of a set genes, including LIFR and KLF4. LIFR upon activation of PI3K pathway,
    and activated AKT phosphorylates downstream target such as CREB and BRCA1, promoting
    tumor growth. KLF4 facilitates transcription of EMT pathways, leading to tumor
    metastasis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SART3
  - PDPK1
  - KMT2D
  - LIF
  - LIFR
  - OSM
  - PIK3R4
  - AKT3
  - PIK3R6
  - PIK3R5
  - CTF1
  - PIK3R3
  - AKT1
  - KLF4
  - AKT2
  - PIK3CG
  - PIK3CA
  - PIK3CD
  - PIK3CB
  - H3K4me1
genes:
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: PDPK1
  symbol: PDPK1
  source: hgnc_symbol
  hgnc_symbol: PDPK1
  entrez: '5170'
- word: KMT2D
  symbol: KMT2D
  source: hgnc_symbol
  hgnc_symbol: KMT2D
  entrez: '8085'
- word: LIF
  symbol: LIF
  source: hgnc_symbol
  hgnc_symbol: LIF
  entrez: '3976'
- word: LIFR
  symbol: LIFR
  source: hgnc_symbol
  hgnc_symbol: LIFR
  entrez: '3977'
- word: OSM
  symbol: OSM
  source: hgnc_symbol
  hgnc_symbol: OSM
  entrez: '5008'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: CT1
  symbol: CT-1
  source: hgnc_alias_symbol
  hgnc_symbol: CTF1
  entrez: '1489'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: KLF4
  symbol: KLF4
  source: hgnc_symbol
  hgnc_symbol: KLF4
  entrez: '9314'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals:
- word: H3K4me1
  source: MESH
  identifier: C024755
diseases: []
figid_alias: PMC6168472__F7
redirect_from: /figures/PMC6168472__F7
figtype: Figure
---
